Synthesis, cytotoxic and antioxidant evaluation of some new N-{5- [(4-fluorophenyl) carbonyl]-1H-benzimidazol-2-yl} -2-(3-oxo-2, 3- dihydro-1H-substitutedisoindol-1-yl) hydrazine carboxamides
IOSR Journal of Pharmacy and Biological Sciences · 2015-02 · 10 (2) · 50-53
DOI: 10.9790/3008-10235053 ↗Kurz gefasst
Fachartikel in der Zeitschrift IOSR Journal of Pharmacy and Biological Sciences, 2015-02. Verfasst von Kolanpaka Priyanka B und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The present study involves synthesis of new heterocyclic moieties and screening them for cytotoxic and antioxidant activities. The titled compounds were synthesized by condensation reaction with different substituted isatin derivatives. The compounds were evaluated for their cytotoxic activity by MTT assay method and antioxidant activity by DPPH method. Among the compounds para chloro derivative was active as cytotoxic and ortho fluoro derivative was active as an antioxidant.
Zitieren
APA
B, K. P., & Sammaiah, G. (2015). Synthesis, cytotoxic and antioxidant evaluation of some new N-{5- [(4-fluorophenyl) carbonyl]-1H-benzimidazol-2-yl} -2-(3-oxo-2, 3- dihydro-1H-substitutedisoindol-1-yl) hydrazine carboxamides. IOSR Journal of Pharmacy and Biological Sciences, 10(2), 50-53. https://doi.org/10.9790/3008-10235053
Vancouver
B KP, Sammaiah G. Synthesis, cytotoxic and antioxidant evaluation of some new N-{5- [(4-fluorophenyl) carbonyl]-1H-benzimidazol-2-yl} -2-(3-oxo-2, 3- dihydro-1H-substitutedisoindol-1-yl) hydrazine carboxamides. IOSR Journal of Pharmacy and Biological Sciences. 2015;10(2):50-53. doi:10.9790/3008-10235053
BibTeX
@article{B2015,
author = {B, Kolanpaka Priyanka and Sammaiah, Gade},
title = {Synthesis, cytotoxic and antioxidant evaluation of some new N-5- [(4-fluorophenyl) carbonyl]-1H-benzimidazol-2-yl -2-(3-oxo-2, 3- dihydro-1H-substitutedisoindol-1-yl) hydrazine carboxamides},
journal = {IOSR Journal of Pharmacy and Biological Sciences},
year = {2015},
volume = {10},
number = {2},
pages = {50--53},
doi = {10.9790/3008-10235053}
}
EUVIMED